NCT05188703Completed
Patient Navigator Intervention for Diabetic Retinopathy
Undiagnosed Diabetic Retinopathy: Using Participatory Science to Design an Intervention for Patients at High-Risk for Blindness
Source: ClinicalTrials.gov · Last updated 11 Mar 2026
Brief summary (registry, in English)
This is a pilot study of a patient navigator intervention for people living with diabetes and at high risk of diabetic blindness. The investigators are assessing the feasibility and acceptability of the intervention in preparation for a clinical trial.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 35 (actual)
- First submitted
- 22 Dec 2021
- Start date
- 25 Jul 2022
- Primary completion date
- 19 Sept 2024
- Lead sponsor
- Yale University
- Diseases
- Diabetic eye disease
- NCT number
- NCT05188703
What you commit to
- Study type: Interventional
- Participants enrolled: 35
- From 25 Jul 2022 to the primary completion date, 19 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diabetes diagnosis not recorded in EPIC
Other
- Documented eye exam in the past year
- Not high risk for diabetic retinopathy
Who the study is looking for
- Adults aged 18 and over
- Diagnosis of diabetes and record of diagnosis in YNHHS EPIC
- English-speaking
- No documented eye examination within 1 year of study enrollment
- High risk for diabetic retinopathy based on risk calculator evaluation
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Yale School of Medicine Coordinator of this site? Confirm its status | New Haven | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.